BlackRock Advisors’s Achieve Life Sciences ACHV Stock Holding History

BlackRock Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$19K	Sell	18 -12	-40%	-$11.9K	﹤0.01%	3459
2016 Q3	$33K	Sell	30 -25	-45%	-$39.9K	﹤0.01%	3343
2016 Q2	$121K	Sell	55 -16	-23%	-$33.4K	﹤0.01%	2868
2016 Q1	$106K	Sell	71 -1	-1%	-$1.63K	﹤0.01%	2892
2015 Q4	$191K	Sell	72 -2	-3%	-$8.45K	﹤0.01%	2592
2015 Q3	$362K	Sell	74 -16	-18%	-$96.4K	﹤0.01%	2408
2015 Q2	$459K	Sell	90 -2	-2%	-$9.92K	﹤0.01%	2239
2015 Q1	$436K	Hold	92	–	–	﹤0.01%	2176
2014 Q4	$465K	Hold	92	–	–	﹤0.01%	2049
2014 Q3	$542K	Sell	92 -3	-3%	-$20.8K	﹤0.01%	1902
2014 Q2	$780K	Buy	95 +2	+2%	+$24.6K	﹤0.01%	1673
2014 Q1	$2.41M	Sell	93 -9	-9%	-$221K	﹤0.01%	1134
2013 Q4	$1.86M	Buy	102 +95	+1,357%	+$1.67M	﹤0.01%	1213
2013 Q3	$149K	Buy	7 +3	+75%	+$62.1K	﹤0.01%	2713
2013 Q2	$94K	Buy	+4	New	+$89.5K	﹤0.01%	2937

Other funds holding ACHV

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Advisors's ACHV Position: Q4 2016 in Review

BlackRock Advisors reduced its Achieve Life Sciences (ACHV) stake by 40% in Q4 2016, selling an estimated $11.9K and leaving 18 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

BlackRock Advisors first reported a position in ACHV in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.41M in Q1 2014. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2016.

BlackRock Advisors held 18 shares of Achieve Life Sciences worth $19K as of Q4 2016.
BlackRock Advisors sold 12 Achieve Life Sciences shares in Q4 2016, an estimated $11.9K.
Achieve Life Sciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3459 holding.
BlackRock Advisors first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Achieve Life Sciences position peaked at $2.41M in Q1 2014.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.